Switzerland· 58073007
Fosrenol
A lanthanum carbonate product containing lanthanum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Lanthanum carbonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE03 (lanthanum carbonate), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 6 of them publish a price we can compare per daily dose
Lanthanum carbonate · ATC V03AE03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of lanthanum carbonate costs, country by country.
Normalised to the WHO defined daily dose (2.25 g), so markets compare like for like.
- Switzerland: $9.20 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Lanthanum carbonate · price per daily dose (2.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.20
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- lanthanum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- V03AE03
- ATC class
- Lanthanum carbonate
- Defined daily dose
- 2.25 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768058073007390 StkCHF 154.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
75 interactions on record for lanthanum carbonate.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lanthanum carbonate · interactions on record
75 records
- 2 severe
- 73 moderate
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lanthanum carbonate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFosrenolTakeda Pharmaceuticals America, Inc.
- United KingdomFosrenol 500mg chewable tabletsTakeda UK Ltd
- SwedenFosrenol 500 mg TuggtablettOrifarm AB
- FranceFOSRENOL 500 mg, comprimé à croquerTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- NorwayFosrenolTakeda Pharmaceuticals International AG Ireland Branch
- IrelandFoznol 500 mg Chewable TabletsTakeda Pharmaceuticals International AG Ireland Branch
- IcelandFosrenolTakeda Pharmaceuticals International AG Ireland Branch
- CanadaNAT-LANTHANUMNATCO PHARMA (CANADA) INC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Fosrenol
- Belgium · Fosrenol
- Cyprus · Fosrenol
- Czechia · Fosrenol
- Germany · Fosrenol, Lanthan Mylan
- Denmark · Fosrenol, Lanthanum Orifarm
- Estonia · Calafos, Fosrenol
- Spain · Fosrenol
- Finland · Fosrenol
- France · Fosrenol, Lanthane Viatris
- United Kingdom (Northern Ireland) · Fosrenol, Lanthanum Mylan
- Greece · Fosrenol
- Croatia · Lantan
- Hungary · Fosrenol
- Ireland · Foznol
- Iceland · Fosrenol
- Italy · Foznol
- Lithuania · Calafos, Fosrenol
- Luxembourg · Fosrenol
- Latvia · Calafos, Fosrenol
- Malta · Foznol
- Netherlands · Fosrenol, Lanthaan Viatris
- Norway · Fosrenol, Lanthanum Orifarm
- Sweden · Fosrenol, Lanthanum Orifarm
- Slovenia · Fosrenol
- Slovakia · Fosrenol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef8bfbed-291a-4f3d-bde4-59b5f0b1eeec GET /v1/drugs/ef8bfbed-291a-4f3d-bde4-59b5f0b1eeec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "lanthanum 500 mg",
"valid_from": "2008-03-01",
"limitations": "[{\"description\":\"Unmöglichkeit, ein Kalzium-Phosphatprodukt von 4.4 oder weniger mit einem Chelatbildner auf Kalzium-Basis, welcher nicht mehr als 1,5 g elementares Kalzium enthält, zu erreichen.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2007-01-01\",\"validTo\":null}]",
"galenic_form": "Kautabl 500 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2008-03-01",
"self_retention_pct": 10
}See everything about lanthanum carbonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.